AstraZeneca(AZN) - 2025 Q4 - Earnings Call Transcript

AstraZeneca (NasdaqGS:AZN) Q4 2025 Earnings call February 10, 2026 06:45 AM ET Company ParticipantsAndy Barnett - Head of Investor RelationsAradhana Sarin - CFODave Fredrickson - EVP, Oncology Business UnitGraham Parry - Head of Healthcare Equity ResearchIskra Reic - EVP, Europe & CanadaMarc Dunoyer - CEO, AlexionPascal Soriot - CEORajan Sharma - Executive Director, Pharma and Biotech Equity ResearchRuud Dobber - EVP, BioPharmaceuticals Business UnitSharon Barr - EVP, BioPharmaceuticals R&DSusan Galbraith - ...